$1.38
-0.09[-6.12%]
At close: Apr 17
$1.38
0[0.00%]
After Hours: 4:23PM EDT
Corvus Pharma
(NASDAQ:CRVS)Corvus Pharma Stock (NASDAQ:CRVS), Quotes and News Summary
Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.
| Open | $1.500 |
| Close | $1.360 |
| Volume / Avg. | 112.527K / 201.508K |
| Day Range | 1.360 - 1.510 |
| 52 Wk Range | 0.977 - 4.190 |
| Market Cap | $67.673M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 25 |
| Short Interest | 3.79% |
| Days to Cover | 5.53 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Corvus Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and ant...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Corvus Pharma (CRVS) stock?
You can purchase shares of Corvus Pharma (NASDAQ: CRVS) through any online brokerage.
Who are Corvus Pharma's (CRVS) competitors?
Other companies in Corvus Pharma’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR), Aligos Therapeutics (NASDAQ:ALGS) and Cue Biopharma (NASDAQ:CUE).
What is the target price for Corvus Pharma (CRVS) stock?
The latest price target for Corvus Pharma (NASDAQ: CRVS) was reported by Cantor Fitzgerald on Monday, April 1, 2024. The analyst firm set a price target for 0.00 expecting CRVS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Corvus Pharma (CRVS)?
The stock price for Corvus Pharma (NASDAQ: CRVS) is $1.38 last updated April 17, 2024 at 4:23 PM EDT.
Does Corvus Pharma (CRVS) pay a dividend?
There are no upcoming dividends for Corvus Pharma.
When is Corvus Pharma (NASDAQ:CRVS) reporting earnings?
Corvus Pharma’s Q1 earnings are confirmed for Monday, May 6, 2024.
Is Corvus Pharma (CRVS) going to split?
There is no upcoming split for Corvus Pharma.
What sector and industry does Corvus Pharma (CRVS) operate in?
Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.